RE:RE:RE:RE:RE:CEO and COO should be replaced by end of Feb
A sale is very likely where we are headed. If that is in fact the case lets hope that the US "investors' can take the necessary steps to enlighten potential buyers to what MCNA's value really is. I don't know whether it would be best to leave management as is to hammer out another trial protocol with the FDA and then sell (if the had a stake I'd lean more this way), or sell the whole nut now and let the new buyer build their own trial? whatever the solution is we are owed a hell of alot more than what we have received to date.